Original Query: ALL
Previous Study | Return to List | Next Study

A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00226980
Recruitment Status : Completed
First Posted : September 27, 2005
Last Update Posted : April 14, 2009
Celgene Corporation
Information provided by:
Stanford University

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2005
  Study Completion Date : July 2006